Withania somnifera as a Potential Anxiolytic and Anti-inflammatory Candidate Against Systemic Lipopolysaccharide-Induced Neuroinflammation
Reactive gliosis, microgliosis, and subsequent secretion of various inflammatory mediators like cytokines, proteases, reactive oxygen, and nitrogen species are the suggested key players associated with systemic inflammation-driven neuroinflammation and cognitive impairments in various neurological disorders. Conventionally, non-steroidal anti-inflammatory drugs are prescribed to suppress inflammation but due to their adverse effects, their usage is not well accepted. Natural products are emerging better therapeutic agents due to their affordability and inherent pleiotropic biological activities. In Ayurveda, Ashwagandha (Withania somnifera) is well known for its immunomodulatory properties. The current study is an extension of our previous report on in vitro model system and was aimed to investigate anti-neuroinflammatory potential of water extract from the Ashwagandha leaves (ASH-WEX) against systemic LPS-induced neuroinflammation and associated behavioral impairments using in vivo rat model system. Oral feeding of ASH-WEX for 8 weeks significantly ameliorated the anxiety-like behavior as evident from Elevated plus maze test. Suppression of reactive gliosis, inflammatory cytokines production like TNF-α, IL-1β, IL-6, and expression of nitro-oxidative stress enzymes like iNOS, COX2, NOX2 etc were observed in ASH-WEX-treated animals. NFκB, P38, and JNK MAPKs pathways analysis showed their involvement in inflammation suppression which was further confirmed by inhibitor studies. The current study provides first ever preclinical evidence and scientific validation that ASH-WEX exhibits the anti-neuroinflammatory potential against systemic LPS-induced neuroinflammation and ameliorates associated behavioral abnormalities. Aqueous extract from Ashwagandha leaves and its active phytochemicals may prove to be promising candidates to prevent neuroinflammation associated with various neuropathologies.
KeywordsAshwagandha Lipopolysaccharide Reactive gliosis Neuroinflammation Anxiety-like behavior Inflammatory cytokines
The current research work was funded by Department of Biotechnology (DBT), Government of India (GOI) to Prof. Gurcharan Kaur (Grant No: BT/PR12200/MED/30/1439/2014). Muskan Gupta is thankful to Council of Scientific and Industrial Research (CSIR), India for the fellowship. Infrastructure provided by University Grants Commission (UGC), India under UPE and CPEPA schemes and Department of Biotechnology (DBT), India under DISC facility is highly acknowledged. Shaffi Manchanda, Taranjeet Kaur, Anuradha Sharma, Harpal Singh, and Manpreet Kaur are deeply acknowledged for their help and support during experimental study. The funding source had no role in study design; collection, analysis, and interpretation of data; in writing of report; and in decision to submit the article for publication.
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures of animal handling and experiments were conducted in accordance with the guidelines laid down by the Institutional Animal Ethical Committee (IAEC) of Guru Nanak Dev University, Amritsar, Punjab, India (Registration number: 226/CPCSEA) and that the studies have been approved by Institutional Animal Ethical Committee (IAEC) of Guru Nanak Dev University, Amritsar, Punjab, India (226/CPCSEA/2015/18). This article does not contain any studies with human participants performed by any of the authors.
- Bachstetter, A. D., Xing, B., de Almeida, L., Dimayuga, E. R., Watterson, D. M., & Van Eldik, L. J. (2011). Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ). Journal of Neuroinflammation, 8(1), 79.CrossRefPubMedPubMedCentralGoogle Scholar
- Badger, A. M., Cook, M. N., Lark, M. W., Newman-Tarr, T. M., Swift, B. A., Nelson, A. H., et al. (1998). SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes. The Journal of Immunology, 161(1), 467–473.PubMedGoogle Scholar
- Bargagna-Mohan, P., Paranthan, R. R., Hamza, A., Dimova, N., Trucchi, B., Srinivasan, C., et al. (2010). Withaferin A targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosis. Journal of Biological Chemistry, 285(10), 7657–7669.CrossRefPubMedGoogle Scholar
- Bossù, P., Cutuli, D., Palladino, I., Caporali, P., Angelucci, F., Laricchiuta, D., et al. (2012). A single intraperitoneal injection of endotoxin in rats induces long-lasting modifications in behavior and brain protein levels of TNF-α and IL-18. Journal of Neuroinflammation, 9(1), 101.CrossRefPubMedPubMedCentralGoogle Scholar
- Grover, A., Shandilya, A., Punetha, A., Bisaria, V. S., & Sundar, D. (2010). Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera’s key metabolite withaferin A. BMC Genomics, 11(4), S25.CrossRefPubMedPubMedCentralGoogle Scholar
- Lowenstein, C. J., Alley, E. W., Raval, P., Snowman, A. M., Snyder, S. H., Russell, S. W., & Murphy, W. J. (1993). Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proceedings of the National Academy of Sciences USA, 90(20), 9730–9734.CrossRefGoogle Scholar
- Moon, Y. J., Lee, J. Y., Oh, M. S., Pak, Y. K., Park, K. S., Oh, T. H., & Yune, T. Y. (2012). Inhibition of inflammation and oxidative stress by Angelica dahuricae radix extract decreases apoptotic cell death and improves functional recovery after spinal cord injury. Journal of Neuroscience Research, 90(1), 243–256.CrossRefPubMedGoogle Scholar
- Narinderpal, K., Junaid, N., & Raman, B. (2013). A Review on pharmacological profile of Withania somnifera (Ashwagandha). Research and Reviews: Journal of Botanical Sciences, 2, 6–14.Google Scholar
- Pietersma, A., Tilly, B. C., Gaestel, M., de Jong, N., Lee, J. C., Koster, J. F., & Sluiter, W. (1997). p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochemical and Biophysical Research Communications, 230(1), 44–48.CrossRefPubMedGoogle Scholar
- Pratte, M. A., Nanavati, K. B., Young, V., & Morley, C. P. (2014). An alternative treatment for anxiety: A systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera). The Journal of Alternative and Complementary Medicine, 20(12), 901–908.CrossRefPubMedGoogle Scholar
- Sinsimer, K. S., Gratacós, F. M., Knapinska, A. M., Lu, J., Krause, C. D., Wierzbowski, A. V., et al. (2008). Chaperone Hsp27, a novel subunit of AUF1 protein complexes, functions in AU-rich element-mediated mRNA decay. Molecular and Cellular Biology, 28(17), 5223–5237.CrossRefPubMedPubMedCentralGoogle Scholar
- Sun, G. Y., Li, R., Cui, J., Hannink, M., Gu, Z., Fritsche, K. L., et al. (2016). Withania somnifera and its withanolides attenuate oxidative and inflammatory responses and up-regulate antioxidant responses in BV-2 microglial cells. Neuromolecular Medicine, 18(3), 241–252.CrossRefPubMedGoogle Scholar
- Udayakumar, R., Kasthurirengan, S., Mariashibu, T. S., Rajesh, M., Anbazhagan, V. R., Kim, S. C., et al. (2009). Hypoglycaemic and hypolipidaemic effects of Withania somnifera root and leaf extracts on alloxan-induced diabetic rats. International Journal of Molecular Sciences, 10(5), 2367–2382.CrossRefPubMedPubMedCentralGoogle Scholar
- Ven Murthy, M. R., Ranjekar, K., Ramassamy, C., & Deshpande, M. (2010). Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: 1. Ashwagandha. Central Nervous System Agents in Medicinal Chemistry, 10(3), 238–246.CrossRefPubMedGoogle Scholar
- Yamamoto, K., Arakawa, T., Ueda, N., & Yamamoto, S. (1995). Transcriptional roles of nuclear factor B and nuclear factor-interleukin-6 in the tumor necrosis factor-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. Journal of Biological Chemistry, 270(52), 31315–31320.CrossRefPubMedGoogle Scholar
- Yuan, L., Wu, Y., Ren, X., Liu, Q., Wang, J., & Liu, X. (2014). Isoorientin attenuates lipopolysaccharide-induced pro-inflammatory responses through down-regulation of ROS-related MAPK/NF-κB signaling pathway in BV-2 microglia. Molecular and Cellular Biochemistry, 386(1–2), 153–165.CrossRefPubMedGoogle Scholar
- Zeng, K. W., Zhang, T., Fu, H., Liu, G. X., & Wang, X. M. (2012). Modified Wu-Zi-Yan-Zong prescription, a traditional Chinese polyherbal formula, suppresses lipopolysaccharide-induced neuroinflammatory processes in rat astrocytes via NF-κB and JNK/p38 MAPK signaling pathways. Phytomedicine, 19(2), 122–129.CrossRefPubMedGoogle Scholar